China-Biotics hits public offering target
This article was originally published in The Tan Sheet
Probiotics manufacturer China-Biotics reports net proceeds of $65.5 million in its underwritten public offering of shares Oct. 5 on NASDAQ. It sold all of the 4.6 million shares of common stock it made available at $15 per share, the target price it set. The Shanghai-based firm said it intends to use the proceeds for general corporate purposes, including expanding its Shining retail operations and product lines and acquiring additional retail outlets. China-Biotics' products are available in pharmacies and supermarkets in Shanghai, Jiangsu and Zhejiang
You may also be interested in...
Herbalife sales hit by currency exchange: Fourth-quarter net sales grow 23 percent to $630.9 million, though the effects of foreign currency fluctuation trim Herbalife's full-year sales 1.5 percent to $2.32 billion. The multilevel marketer of nutritional and weight-management products reported dramatic quarterly gains in net sales in the Asia Pacific region - up 56.2 percent to $151.5 million - and in South and Central America - up 34 percent to $113.2 million. Sales were flat or down in Mexico - affected by a value-added tax and distribution challenges - and in China, where sales leaders still are implementing the daily consumption model, Herbalife executives said Feb. 24. The Los Angeles firm said net income for the October-December period jumped 65.4 percent to $55.7 million, but dipped 8.1 percent to $203.3 million for the full year. Herbalife introduced more than 60 new or reformulated products across 72 countries during the year, CEO Michael Johnson said. The company projects net sales growth of 12.5 percent to 13.5 percent for its fiscal 2010 first quarter, and growth between 8.5 percent and 9.5 percent for the year
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.